Literature DB >> 31062326

The Roles of Apolipoprotein E, Lipids, and Glucose in the Pathogenesis of Alzheimer's Disease.

Mitsuru Shinohara1, Naoyuki Sato2.   

Abstract

Although the mechanisms by which Alzheimer's disease (AD) occurs remains unclear, it is widely accepted that both genetic and nongenetic components contribute to the pathogenesis of AD, especially the sporadic form of the disease. Nongenetic risk factors include diabetes and dyslipidemia, which are associated with impaired glucose and lipid metabolism, respectively. Apolipoprotein E (ApoE), one of the major lipid carriers in the brain, is the strongest genetic risk factor for late-onset AD. Several studies indicate that ApoE isoforms differentially affect not only lipid metabolism but also glucose metabolism or related pathways, suggesting that these risk factors contribute to the pathogenesis of AD through some common mechanisms. In this chapter, we discuss the roles of ApoE, lipids, and glucose in the pathogenesis of AD by considering their potential interactions.

Entities:  

Keywords:  Alzheimer’s disease; ApoE; Aβ; Cerebrovascular damage; Cholesterol; Cognitive dysfunction; Diabetes; Dyslipidemia; Glucose; Insulin signaling; Lipids; Neurodegeneration; Neuroinflammation; Tau

Mesh:

Substances:

Year:  2019        PMID: 31062326     DOI: 10.1007/978-981-13-3540-2_5

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  6 in total

Review 1.  ApoE Lipidation as a Therapeutic Target in Alzheimer's Disease.

Authors:  Maria Fe Lanfranco; Christi Anne Ng; G William Rebeck
Journal:  Int J Mol Sci       Date:  2020-09-01       Impact factor: 5.923

2.  27-Hydroxycholesterol, cognition, and brain imaging markers in the FINGER randomized controlled trial.

Authors:  Alina Solomon; Miia Kivipelto; Anna Sandebring-Matton; Julen Goikolea; Ingemar Björkhem; Laura Paternain; Nina Kemppainen; Tiina Laatikainen; Tiia Ngandu; Juha Rinne; Hilkka Soininen; Angel Cedazo-Minguez
Journal:  Alzheimers Res Ther       Date:  2021-03-06       Impact factor: 6.982

3.  Apolipoprotein E Induced Cognitive Dysfunction: Mediation Analysis of Lipids and Glucose Biomarkers in an Elderly Cohort Study.

Authors:  Linxin Liu; Huichu Li; Hari Iyer; Andy J Liu; Yi Zeng; John S Ji
Journal:  Front Aging Neurosci       Date:  2021-08-13       Impact factor: 5.750

4.  Electroacupuncture could balance the gut microbiota and improve the learning and memory abilities of Alzheimer's disease animal model.

Authors:  Jing Jiang; Hao Liu; Zidong Wang; Huiling Tian; Shun Wang; Jiayi Yang; Jingyu Ren
Journal:  PLoS One       Date:  2021-11-08       Impact factor: 3.240

5.  Effects of toxic apolipoprotein E fragments on Tau phosphorylation and cognitive impairment in neonatal mice under sevoflurane anesthesia.

Authors:  Yang Yu; Man Yang; Xiaoli Zhuang; Jiacheng Pan; Yue Zhao; Yonghao Yu
Journal:  Brain Behav       Date:  2022-07-10       Impact factor: 3.405

6.  Microglia prevent beta-amyloid plaque formation in the early stage of an Alzheimer's disease mouse model with suppression of glymphatic clearance.

Authors:  Weixi Feng; Yanli Zhang; Ze Wang; Hanrong Xu; Ting Wu; Charles Marshall; Junying Gao; Ming Xiao
Journal:  Alzheimers Res Ther       Date:  2020-10-02       Impact factor: 6.982

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.